Glycine receptors: A new therapeutic target in pain pathways

Current Opinion in Investigational Drugs

Volumn 7, Issue 1, 2006, Pages 48-53

  Lynch, Joseph W ^a   Callister, Robert J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Analgesia; Chloride channel; Drug discovery; Inflammatory pain; Inhibitory neurotransmission; Neuropathic pain; Spinal cord

Indexed keywords

GLYCINE RECEPTOR; OPIATE; RECEPTOR SUBUNIT;

ANALGESIA; CHRONIC PAIN; DRUG TARGETING; GENE DELETION; HUMAN; INFLAMMATION; NERVE TRACT; NEUROBIOLOGY; NEUROPATHIC PAIN; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PAIN; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SENSORY SYSTEM; SPINAL CORD; SPINAL CORD NERVE CELL; SPINAL REFLEX; THEORY;

AFFERENT PATHWAYS; ANALGESICS; ANIMALS; EFFERENT PATHWAYS; HUMANS; PAIN; RECEPTORS, GLYCINE;

EID: 30944455443     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Willis WD, Coggeshall RE: Sensory machanisms of the spinal cord, Third Edition. Kluwer Academic/Plenum Publishers, New York, NY, USA (2004).
2. Millan MJ: Descending control of pain. Prog Neurobiol (2002) 66(6):355-474.
3. Gebhart GF: Descending modulation of pain. Neurosci Biobehav Rev (2004) 27(8):729-737.
4. Woolf CJ, Salter MW: Neuronal plasticity: Increasing the gain in pain. Science (2000) 288(5472):1765-1769.
5. A and glycine receptors to central sensitization: Disinhiblition and touch-evoked allodynia in the spinal cord. J Neurophysiol (1994) 72(1):169-179.
6. Basbaum AI, Fields HL: Endogenous pain control systems: Brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci (1984) 7:309-338.
7. Harvey RJ, Depner UB, Wassle H, Ahmadi S, Heindl C, Reinold H, Smart TG, Harvey K, Schutz B, Abo-Salem OM, Zimmer A et al: GlyR α3: An essential target for spinal PGE2-mediated inflammatory pain sensitization. Science (2004) 304(5672):884-887.
8. Willis WD, Westlund KN: Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol (1997) 14(1):2-31.
9. Price DD: Central neural mechanisms that interrelate sensory and affective dimensions of pain. Mol Interv (2002) 2(6):392-403.
10. Craig AD: How do you feel? Interoception: The sense of the physiological condition of the body. Nat Rev Neurosci (2002) 3(8):655-666.
11. Craig AD: Pain mechanisms: Labeled lines versus convergence in central processing. Annu Rev Neurosci (2003) 26(1):1-30.
12. A receptor-mediated IPSCs in identified lamina I neurons of the adult rat spinal cord. J Neurosci (1999) 19(17):7342-7355.
13. Graham BA, Schofield PR, Sah P, Callister RJ: Altered inhibitory synaptic transmission in superficial dorsal horn neurones in spastic and oscillator mice. J Physiol (2003) 551(3):905-916.
14. A- and glycine-receptor mediated tonic inhibition in the dorsal horn of the rat lumber spinal cord: Effects of picrotoxin and strychnine on expression of Fos-like immunoreactivtty. Pain (2004) 112(1-2):156-163.
15. Baccei ML, Fitzgerald M: Development of GABAergic and glycinergic transmission in the neonatal rat dorsal horn. J Neurosci (2004) 24(20):4749-4757.
16. Todd AJ, Watt C, Spike RC, Sieghart W: Colocalization of GABA, glycine, and their receptors at synapses in the rat spinal cord. J Neurosci (1996) 16(3):974-982.
17. Maxwell DJ, Todd AJ, Kerr R: Colocalization of glycine and GABA in synapses on spinomedullary neurons. Brain Res (1995) 690(1):127-132.
18. Sugiura Y, Lee CL, Perl ER: Central projections of identified, unmyelinated (C) afferent fibers innervating mammalian skin. Science (1986) 234(4774):358-361.
19. Light AR, Perl ER: Spinal termination of functionally identified primary afferent neurons with slowly conducting myelinated fibers. J Comp Neurol (1979) 186(2):133-150.
20. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK: Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain (2005) 9(4):463-484.
21. Lu Y, Perl ER: A specific inhibitory pathway between substantia gelatinosa neurons receiving direct C-fiber input. J Neurosci (2003) 23(25):8752-8758.
22. Lu Y, Perl ER: Modular organization of excitatory circuits between neurons of the spinal superficial dorsal horn (laminae I and II). J Neurosci (2005) 25(15):3900-3907.
23. Yoshimura M, Jessell T: Amino acid-mediated EPSPs at primary afferent synapses with substantia gelatinosa neurones in the rat spinal cord. J Physiol (1990) 430:315-335.
24. Cervero F, Iggo A: The substantia gelatinosa of the spinal cord: A critical review. Brain (1980) 103(4):717-772.
25. Light AR, Kavookjian AM: Morphology and ultrastructure of physiologically identified substantia gelatinosa (lamina II) neurons with axons that terminate in deeper dorsal horn laminae (III-V). J Comp Neurol (1988) 267(2):172-189.
26. Reynolds DV: Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science (1969) 164(878):444-445.
27. Young RF, Brechner T: Electrical stimulation of the brain for relief of intractable pain due to cancer. Cancer (1986) 57(8):1268-1272.
28. Ren K, Dubner R: Descending modulation in persistent pain: An update. Pain (2002) 100(1-2):1-6.
29. Fields HL: Pain modulation: Expectation, opioid analgesia and virtual pain. Prog Brain Res (2000) 122:245-253.
30. Pan ZZ, Fields HL: Endogenous opioid-mediated inhibition of putative pain-modulating neurons in rat rostral ventromedial medulla. Neuroscience (1996) 74(3):855-862.
31. Urban MO, Gebhart GF: Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA (1999) 96(14):7687-7692.
32. Urban MO, Gebhart GF: Central mechanisms in pain. Med Clin North Am (1999) 83(3):585-596.
33. Somogyi J, Llewellyn-Smith IJ: Patterns of colocalization of GABA, glutamate and glycine immunoreactivities in terminals that synapse on dendrites of noradrenergic neurons in rat locus coeruleus. Eur J Neurosci (2001) 14(2):219-228.
34. Peng YB, Lin Q, Willis WD: Effects of GABA and glycine receptor antagonists on the activity and PAG-induced inhibition of rat dorsal horn neurons. Brain Res (1996) 736(1-2):189-201.
35. A antagonists reduce the inhibition of primate spinothalamic tract neurons produced by stimulation in periaqueductal gray. Brain Res (1994) 654(2):286-302.
36. Araki T, Yamano M, Murakami T, Wanaka A, Betz H, Tohyama M: Localization of glycine receptors in the rat central nervous system: An immunocytochemical analysis using monoclonal antibody. Neuroscience (1988) 25(2):613-624.
37. Sato K, Zhang JH, Saika T, Sato M, Tada K, Tohyama M: Localization of glycine receptor α 1 subunit mRNA-containing neurons in the rat brain: An analysis using in situ hybridization histochemistry. Neuroscience (1991) 43(2-3):381-395.
38. Light AR, Casale EJ, Menetrey DM: The effects of focal stimulation in nucleus raphe magnus and periaqueductal gray on intracellularly recorded neurons in spinal laminae I and II. J Neurophysiol (1986) 56(3):555-571.
39. Melzack R, Wall PD: Pain mechanisms: A new theory. Science (1965) 150(699):971-979.
40. Lundberg A, Norrssell U, Voorhoeve P: Effects from the sensory motor cortex on ascending spinal pathways. Acts Physiol Scand (1963) 59:462-473.
41. Yoshimura M, Nishi S: Primary afferent-evoked glycine- and GABA-mediated IPSPs in substantia gelatinosa neurones in the rat spinal cord in vitro. J Physiol (1995) 482(1):29-38.
42. Keller AF, Coull JA, Chery N, Polsbeau P, De Koninck Y: Region-specific developmental specialization of GABA-glycine cosynapses in laminas I-II of the rat spinal dorsal horn. J Neurosci (2001) 21(20):7871-7880.
43. Coull JA, Boudreau D, Bachand K, Prescott SA, Nault F, Sik A, De Koninck P, De Koninck Y: Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain. Nature (2003) 424(6951):938-942.
44. Sorkin LS, Puig S: Neuronal model of tactile allodynia produced by spinal strychnine: Effects of excitatory amino acid receptor antagonists and a μ-opiate receptor agonist. Pain (1996) 68(2-3):283-292.
45. Sorkin LS, Puig S, Jones DL: Spinal bicuculline produces hypersensitivity of dorsal horn neurons: Effects of excitatory amino acid antagonists. Pain (1998) 77(2):181-190.
46. Wall PD, Lidierth M, Hillman P: Brief and prolonged effects of Lissauer tract stimulation on dorsal horn calls. Pain (1999) 83(3):579-589.
47. Baba H, Doubell TP, Woolf CJ: Peripheral inflammation facilitates Aβ fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord. J Neurosci (1999) 19(2):859-867.
48. Kontinen VK, Stanfa LC, Basu A, Dickenson AH: Electrophysiologic evidence for increased endogenous gabaergic but not glycinergic inhibitory tone in the rat spinal nerve ligation model of neuropathy. Anesthesiology (2001) 94(2):333-339.
49. Lynch JW: Molecular structure and function of the glycine receptor chloride channel. Physiol Rev (2004) 84(4):1051-1095.
50. Grudzinska J, Schemm R, Haeger S, Nicke A, Schmalzing G, Betz H, Laube B: The β subunit determines the ligand binding properties of synaptic glycine receptors. Neuron (2005) 45(5):727-739.
51. Kneussel M, Betz H: Receptors, gephyrin and gephyrin-associated proteins: Novel insights into the assembly of inhibitory postsynaptic membrane specializations. J Physiol (2000) 525(1):1-9.
52. Becker CM, Hoch W, Betz H: Glycine receptor heterogeneity in rat spinal cord during postnatal development. EMBO J (1988) 7(12):3717-3726.
53. Flint AC, Liu X, Kriegstein AR: Nonsynaptic glycine receptor activation during early neocortical development. Neuron (1998) 20(1):43-53.
54. A receptors in developing spinal cord neurons. Effects on neurite outgrowth. Neuroscience (2001) 108(3):493-506.
55. Aguayo LG, van Zundert B, Tapia JC, Carrasco MA, Alvarez FJ: Changes on the properties of glycine receptors during neuronal development. Brain Res Brain Res Rev (2004) 47(1-3):33-45.
56. Haverkamp S, Muller U, Harvey K, Harvey RJ, Betz H, Wassle H: Diversity of glycine receptors in the mouse retina: Localization of the α3 subunit. J Comp Neurol (2003) 465(4):524-539.
57. Haverkamp S, Muller U, Zeilhofer HU, Harvey RJ, Wassle H: Diversity of glycine receptors in the mouse retina: Localization of the α2 subunit. J Comp Neurol (2004) 477(4):399-411.
58. A receptor genes in the human genome. J Biol Chem (2004) 279(40):41422-41435.
59. Meier JC, Henneberger C, Melnick I, Racca C, Harvey RJ, Heinemann U, Schmieden V, Grantyn R: RNA editing produces glycine receptor α3(P185L), resulting in high agonist potency. Nat Neurosci (2005) 8(6):736-744.
60. Mori M, Gahwiler BH, Gerber U: β-Alanine and taurine as endogenous agonists at glycine receptors in rat hippocampus in vitro. J Physiol (2002) 539(1):191-200.
61. Darstein M, Landwehrmeyer GB, Kling C, Becker CM, Feuerstein TJ: Strychnine-sensitive glycine receptors in rat caudatoputamen are expressed by cholinergic interneurons. Neuroscience (2000) 96(1):33-39.
62. McCool BA, Farroni JS: Subunit composition of strychnine-sensitive glycine receptors expressed by adult rat basolateral amygdala neurons. Eur J Neurosci (2001) 14(7):1082-1090.
63. 2 selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons. Nat Neurosci (2002) 5(1):34-40.